Circulating tumor cells (CTCs) in patients with metastatic castration resistant prostate cancer (mCRPC) treated with olaparib plus 177lutetium-prostate specific membrane antigen-617 (177Lu-PSMA-617) in the LuPARP trial

被引：0
|
作者：
Hamid, Anis
Gupta, Santosh
Keerthikumar, Shivakumar
Pasam, Anupama
Crumbaker, Megan
Joshua, Anthony M.
Lam, Ernest
Wenstrup, Rick
Emmett, Louise
Goode, David L.
Hofman, Michael S.
Sandhu, Shahneen
机构：
[1] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Epic Sci, San Diego, CA USA
[4] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[5] St Vincents Hosp, Sydney, NSW, Australia
[6] Peter MacCallum Canc Ctr, Mol Imaging & Therapeut Nucl Med, Melbourne, Vic, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5064
引用
收藏
页数：1
相关论文
共 50 条
  • [41] 177Lu-PSMA-617 therapy, dosimetry and follow-up in patients with metastatic castration-resistant prostate cancer
    Fendler, Wolfgang P.
    Kratochwil, Clemens
    Ahmadzadehfar, Hojjat
    Rahbar, Kambiz
    Baum, Richard P.
    Schmidt, Matthias
    Pfestroff, Andreas
    Luetzen, Ulf
    Prasad, Vikas
    Heinzel, Alexander
    Heuschkel, Martin
    Ruf, Juri
    Bartenstein, Peter
    Krause, Bernd J.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2016, 55 (03): : 123 - 128
  • [42] Therapeutic response and safety of radioligand therapy with 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer patients
    Ashfaq, Wardah
    Rehman, Khurram
    Shahid, Abubaker
    Younis, Muhammad Numair
    MEDICAL ONCOLOGY, 2024, 41 (09)
  • [43] 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients with a Single Functioning Kidney
    Zhang, Jingjing
    Kulkarni, Harshad R.
    Singh, Aviral
    Schuchardt, Christiane
    Niepsch, Karin
    Langbein, Thomas
    Baum, Richard P.
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (11) : 1579 - 1586
  • [44] Radiobiological parameters for the assessment of 177Lu-PSMA-617 Radioligand Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
    Hu, J.
    Xue, S.
    Mercolli, L.
    Sari, H.
    Rominger, A.
    Afshar-Oromieh, A.
    Shi, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S636 - S636
  • [45] Delayed response after repeated 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer
    Rahbar, Kambiz
    Boegeman, Martin
    Yordanova, Anna
    Eveslage, Maria
    Schaefers, Michael
    Essler, Markus
    Ahmadzadehfar, Hojjat
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (02) : 243 - 246
  • [46] 177Lu-PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer patients with a single functioning kidney
    Zhang, Jingjing
    Kulkarni, Harshad
    Singh, Aviral
    Schuchardt, Christiane
    Niepsch, Karin
    Langbein, Thomas
    Baum, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [47] PRINCE: Interim analysis of the phase Ib study of 177Lu-PSMA-617 in combination with pembrolizumab for metastatic castration resistant prostate cancer (mCRPC)
    Sandhu, S. K.
    Joshua, A. M.
    Emmett, L.
    Spain, L.
    Horvath, L. G.
    Crumbaker, M.
    Anton, A.
    Wallace, R.
    Pasam, A.
    Bressel, M.
    Cassidy, E.
    Banks, P.
    Kumar, A. R.
    Alipour, R.
    Akhurst, T.
    Kong, G.
    Davis, I. D.
    Williams, S.
    Hicks, R.
    Hofman, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S626 - S627
  • [48] Immunogenic priming with 177Lu-PSMA-617 plus pembrolizumab in metastatic castration resistant prostate cancer (mCRPC): A phase 1b study.
    Aggarwal, Rahul Raj
    Sam, Srey Luch
    Koshkin, Vadim S.
    Small, Eric Jay
    Feng, Felix Y.
    de Kouchkovsky, Ivan
    Kwon, Daniel H.
    Friedlander, Terence W.
    Borno, Hala
    Bose, Rohit
    Chou, Jonathan
    Desai, Arpita
    Rodvelt, Tammy J.
    Aslam, Maya
    Rastogi, Medini
    Fong, Lawrence
    Hope, Thomas A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [49] 225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience
    Khreish, Fadi
    Ebert, Niklas
    Ries, Martin
    Maus, Stephan
    Rosar, Florian
    Bohnenberger, Hendrik
    Stemler, Tobias
    Saar, Matthias
    Bartholomae, Mark
    Ezziddin, Samer
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (03) : 721 - 728
  • [50] Delayed response after repeated 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer
    Kambiz Rahbar
    Martin Bögeman
    Anna Yordanova
    Maria Eveslage
    Michael Schäfers
    Markus Essler
    Hojjat Ahmadzadehfar
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 243 - 246
12345